NRGN and Alzheimer disease: Other CSF biomarkers reported to be changed in AD, YKL40 and SNAP25, have also been shown to be increased in DS-AD patients compared with healthy controls;while CSF α-synuclein, sTREM2, and Ng concentrations were not significantly changed [43] -but the study was likely lacking in sufficient statistical power.